Aravive, Inc. (55)
Browse by Contract Category
Contracts
-
Amendment No. 1 to Offer Letter dated as of February 1, 2023 by and between Aravive, Inc. and Leonard Scott Dove, Ph.D
(Filed With SEC on February 6, 2023)
-
Form of Securities Purchase Agreement, dated October 24, 2022, by and among Aravive, Inc. and the purchasers party thereto
(Filed With SEC on October 28, 2022)
-
Separation Agreement and Release, dated June 2, 2022, by and between Aravive, Inc. and Vinay Shah
(Filed With SEC on June 3, 2022)
-
Sublease Agreement by and between Aravive, Inc. and Grail, Inc
(Filed With SEC on June 14, 2021)
-
Collaboration and License Agreement between Aravive, Inc. and 3D Medicines Inc. dated November 6, 2020
(Filed With SEC on November 10, 2020)
-
Amendment No. 1 to Offer Letter dated as of February 1, 2023 by and between Aravive, Inc. and Robert Geller, M.D
(Filed With SEC on February 6, 2023)
-
Amendment No. 1 to Offer Letter dated as of February 1, 2023 by and between Aravive, Inc. and RudyHoward
(Filed With SEC on February 6, 2023)
-
Amendment No. 3 to Offer Letter dated as of February 1, 2023 by and between Aravive, Inc. and Gail McIntyre, Ph.D
(Filed With SEC on February 6, 2023)
-
Form of Securities Purchase Agreement, dated October 24, 2022, by and among Aravive, Inc. and the purchasers party thereto
(Filed With SEC on October 26, 2022)
-
Form of Series A Warrant
(Filed With SEC on October 26, 2022)
-
Form of Series B Warrant
(Filed With SEC on October 26, 2022)
-
Form of Pre-Funded Warrant
(Filed With SEC on October 26, 2022)
-
Form of Side Letter Agreement by and among Aravive, Inc. and the persons party thereto
(Filed With SEC on October 26, 2022)
-
Form of Registration Rights Agreement by and among Aravive, Inc. and the persons party thereto
(Filed With SEC on October 26, 2022)
-
Form of Affiliate Registration Rights Agreement, by and among Aravive, Inc. and the persons party thereto
(Filed With SEC on October 26, 2022)
-
Form of Side Letter Agreement by and among Aravive, Inc. and the BVF Investor party thereto
(Filed With SEC on October 26, 2022)
-
Offer Letter, dated June 13, 2022, by and between Aravive, Inc. and Dr. Robert B. Geller
(Filed With SEC on July 5, 2022)
-
Consulting Agreement, dated June 2, 2022, by and between Aravive, Inc. and Vinay Shah
(Filed With SEC on June 3, 2022)
-
Offer Letter, dated June 2, 2022, by and between Aravive, Inc. and Rudy C. Howard
(Filed With SEC on June 3, 2022)
-
Form of Eshelman Warrant
(Filed With SEC on March 31, 2022)
-
Form of Investor Warrant
(Filed With SEC on March 31, 2022)
-
Form of Securities Purchase Agreement, dated March 29, 2022 by and between Aravive, Inc. and Eshelman Ventures, LLC
(Filed With SEC on March 31, 2022)
-
Form of Pre-Funded Warrant
(Filed With SEC on March 31, 2022)
-
Form of Securities Purchase Agreement, dated March 29, 2022 by and between Aravive, Inc. and the purchaser party thereto
(Filed With SEC on March 31, 2022)
-
Offer Letter between Leonard Scott Dove, Ph.D. and Aravive, Inc
(Filed With SEC on March 22, 2022)
-
Investment Agreement, dated as of January 3, 2022, by and among Aravive, Inc., Eshelman Ventures, LLC, and solely for purposes of Article IV and V of the Investment Agreement,...
(Filed With SEC on January 4, 2022)
-
Form of Pre-Funded Common Stock Purchase Warrant of Aravive, Inc
(Filed With SEC on January 4, 2022)
-
Offer Letter, dated September 8, 2020 between Reshma Rangwala and the Company
(Filed With SEC on March 16, 2021)
-
Description of Capital Securities
(Filed With SEC on March 16, 2021)
-
Securities Purchase Agreement, dated February 12, 2021, by and between Aravive, Inc. and Eshelman Ventures, LLC
(Filed With SEC on February 16, 2021)
-
Amendment to Offer Letter dated as of January 25, 2021 by and between Aravive, Inc. and Gail McIntyre, Ph.D
(Filed With SEC on January 27, 2021)
-
Consulting Agreement, dated December 31, 2020, between the Company and Ray Tabibiazar
(Filed With SEC on January 4, 2021)
-
Separation Agreement dated April 8, 2020 between the Company and Rekha Hemrajani
(Filed With SEC on April 9, 2020)
-
Amendment to Offer Letter dated as of April 8, 2020 by and between the Company and Gail McIntyre
(Filed With SEC on April 9, 2020)
-
Option Agreement dated April 8, 2020 by and between the Company and Robert Hoffman
(Filed With SEC on April 9, 2020)
-
Option Agreement dated April 8, 2020 by and between the Company and Jay Shepard
(Filed With SEC on April 9, 2020)
-
Option Agreement dated April 8, 2020 by and between the Company and Srini Akkaraju
(Filed With SEC on April 9, 2020)
-
Investment Agreement, dated as of April 6, 2020, by and among the Company, Eshelman Ventures, LLC, and, solely for purposes of Article IV and Article V of the Investment...
(Filed With SEC on April 9, 2020)
-
Form of 2019 Equity Incentive Plan Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement
(Filed With SEC on March 27, 2020)
-
Description of Capital Securities
(Filed With SEC on March 27, 2020)
-
Offer Letter, dated March 26, 2020, between Vinay Shah and Aravive, Inc
(Filed With SEC on March 27, 2020)
-
Offer Letter, dated March 26, 2020 between Gail McIntyre and Aravive, Inc
(Filed With SEC on March 27, 2020)
-
Offer Letter, dated January 8, 2020, between Rekha Hemrajani and Aravive, Inc
(Filed With SEC on January 9, 2020)
-
Separation Agreement, dated January 9, 2020, between Jay Shepard and Aravive, Inc
(Filed With SEC on January 9, 2020)
-
Consulting Agreement, dated January 9, 2020, between Jay Shepard and Aravive, Inc
(Filed With SEC on January 9, 2020)
-
Purchase Agreement, dated November 27, 2019, by and among Aravive, Inc., Piper Jaffray & Co. and Cantor Fitzgerald & Co
(Filed With SEC on November 27, 2019)
-
Equity Distribution Agreement, dated as of March 26, 2019, between Aravive, Inc. and Piper Jaffray & Co
(Filed With SEC on March 26, 2019)
-
Non-Employee Director Compensation Policy, as amended January 3, 2019
(Filed With SEC on March 15, 2019)
-
First Amendment to 2014 Equity Incentive Plan
(Filed With SEC on March 6, 2019)
-
Amendment to Jay Shepard Offer Letter dated as of February 28, 2019
(Filed With SEC on March 6, 2019)
-
Severance Agreement dated May 31, 2018 and amendment thereto dated September 24, 2018 between Aravive Biologics, Inc. and Gail McIntyre
(Filed With SEC on February 12, 2019)
-
Offer Letter dated January 1, 2017 by and between Aravive Biologics, Inc. and Gail McIntyre
(Filed With SEC on February 12, 2019)
-
Severance Agreement dated May 31, 2018 and amendment thereto dated September 24, 2018 between Aravive Biologics, Inc. and Vinay Shah
(Filed With SEC on February 12, 2019)
-
Offer Letter dated February 1, 2017 and the amendment thereto dated May 30, 2018 by and between Aravive Biologics, Inc. and Vinay Shah
(Filed With SEC on February 12, 2019)
-
Amendment to Jay Shepard Offer Letter dated as of February 6, 2019
(Filed With SEC on February 12, 2019)